Demographics (2)
- AGE - Subject age at enrollment (phv00491637.v1.p1)
- SEX - Biological sex (phv00491633.v1.p1)
Disease Events (5)
- AGE_ONSET - Disease onset age (phv00491638.v1.p1)
- HR_STATUS - Hormone receptor status of the tumor (phv00491641.v1.p1)
- PRIMARY_TUMOR - Location of primary tumor (phv00491639.v1.p1)
- STAGE - Cancer stage at time of treatment initiation (phv00491640.v1.p1)
- TREATMENT - Treatment received by patient (phv00491642.v1.p1)
Other (11)
- ANALYTE_TYPE - Analyte Type (phv00491645.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00491644.v1.p1)
- COLLECTION_TIME - Time of sample collection relative to initiation of treatment (phv00491648.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00491632.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00491647.v1.p1)
- IS_TUMOR - Tumor status (phv00491646.v1.p1)
- SAMPLE_ID - Sample ID (phv00491643.v1.p1)
- SAMPLE_ID - Sample ID (phv00491635.v1.p1)
- SUBJECT_ID - Subject ID (phv00491636.v1.p1)
- SUBJECT_ID - Subject ID (phv00491631.v1.p1)
- SUBJECT_ID - Subject ID (phv00491634.v1.p1)